Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas M Sproule

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Therapeutic Advances in Neurological Disorders|December 24, 2010
Therapeutic developments in spinal muscular atrophyDouglas M Sproule, Petra Kaufmann
Annals of the New York Academy of Sciences|November 8, 2008
Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndromeDouglas M Sproule, Petra Kaufmann
Archives of Neurology|February 10, 2010
Scoliosis surgery in children with neuromuscular disease: findings from the US National Inpatient Sample, 1997 to 2003Alexandra I Barsdorf, Douglas M Sproule, Petra Kaufmann
Pharmacoeconomics - Open|September 6, 2018
High Healthcare Resource Use in Hospitalized Patients with a Diagnosis of Spinal Muscular Atrophy Type 1 (SMA1): Retrospective Analysis of the Kids' Inpatient Database (KID)Jessica Cardenas, Melissa Menier, Marjet D Heitzer, et al.
Journal of Child Neurology|September 5, 2014
Measuring disease progression in giant axonal neuropathy: implications for clinical trial designLisa A Roth, Jonathan D Marra, Nicole H LaMarca, et al.
Journal of Muscle Research and Cell Motility|April 18, 2024
Validation of a novel western blot assay to monitor patterns and levels of alpha dystroglycan in skeletal muscle of patients with limb girdle muscular dystrophiesThulashitha Rajasingham, Hector M Rodriguez, Andreas Betz, et al.
Muscle & Nerve|June 21, 2014
Giant axonal neuropathy: An updated perspective on its pathology and pathogenesisBethany L Johnson-Kerner, Lisa Roth, J Palmer Greene, et al.
Journal of Child Neurology|April 3, 2012
Age at disease onset predicts likelihood and rapidity of growth failure among infants and young children with spinal muscular atrophy types 1 and 2Douglas M Sproule, Ridda Hasnain, Dorcas Koenigsberger, et al.
Journal of Child Neurology|July 10, 2012
Independent mobility after early introduction of a power wheelchair in spinal muscular atrophySally Dunaway, Jacqueline Montes, Jessica O'Hagen, et al.
Journal of Child Neurology|December 14, 2011
Spinal muscular atrophy type III: trying to understand subtle functional change over time--a case reportSally Dunaway, Jacqueline Montes, Patricia A Ryan, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Therapeutic Advances in Neurological Disorders|December 24, 2010
Therapeutic developments in spinal muscular atrophyDouglas M Sproule, Petra Kaufmann
Annals of the New York Academy of Sciences|November 8, 2008
Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndromeDouglas M Sproule, Petra Kaufmann
Archives of Neurology|February 10, 2010
Scoliosis surgery in children with neuromuscular disease: findings from the US National Inpatient Sample, 1997 to 2003Alexandra I Barsdorf, Douglas M Sproule, Petra Kaufmann
Pharmacoeconomics - Open|September 6, 2018
High Healthcare Resource Use in Hospitalized Patients with a Diagnosis of Spinal Muscular Atrophy Type 1 (SMA1): Retrospective Analysis of the Kids' Inpatient Database (KID)Jessica Cardenas, Melissa Menier, Marjet D Heitzer, et al.
Journal of Child Neurology|September 5, 2014
Measuring disease progression in giant axonal neuropathy: implications for clinical trial designLisa A Roth, Jonathan D Marra, Nicole H LaMarca, et al.
Journal of Muscle Research and Cell Motility|April 18, 2024
Validation of a novel western blot assay to monitor patterns and levels of alpha dystroglycan in skeletal muscle of patients with limb girdle muscular dystrophiesThulashitha Rajasingham, Hector M Rodriguez, Andreas Betz, et al.
Muscle & Nerve|June 21, 2014
Giant axonal neuropathy: An updated perspective on its pathology and pathogenesisBethany L Johnson-Kerner, Lisa Roth, J Palmer Greene, et al.
Journal of Child Neurology|April 3, 2012
Age at disease onset predicts likelihood and rapidity of growth failure among infants and young children with spinal muscular atrophy types 1 and 2Douglas M Sproule, Ridda Hasnain, Dorcas Koenigsberger, et al.
Journal of Child Neurology|July 10, 2012
Independent mobility after early introduction of a power wheelchair in spinal muscular atrophySally Dunaway, Jacqueline Montes, Jessica O'Hagen, et al.
Journal of Child Neurology|December 14, 2011
Spinal muscular atrophy type III: trying to understand subtle functional change over time--a case reportSally Dunaway, Jacqueline Montes, Patricia A Ryan, et al.
Pageof 4